ARS Pharmaceuticals
SPRY
#5093
Rank
ยฃ1.03 B
Marketcap
ยฃ10.68
Share price
-1.25%
Change (1 day)
185.06%
Change (1 year)

Revenue for ARS Pharmaceuticals (SPRY)

Revenue in 2024 (TTM): ยฃ0.39 Million

According to ARS Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is ยฃ0.39 Million. In 2023 the company made a revenue of ยฃ0.02 Million a decrease over the revenue in the year 2022 that were of ยฃ1.08 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for ARS Pharmaceuticals from 2022 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) ยฃ0.39 M1578.19%
2023 ยฃ0.02 M-97.84%
2022 ยฃ1.08 M